Skip to content
Use caution Medical device recall · FDA · Published March 11, 2019

ACUVUE OASYS Contact Lens Recall: Incomplete Seal Hazard

Johnson & Johnson recalls specific ACUVUE OASYS for Astigmatism lenses due to incomplete packaging seals. Check lot B00RWF0 and UPC 733905669460.

🇺🇸 FDA recall #Z-1131-2019Medical deviceACUVUE ›
Take action

Contact the company

Recalling firmJohnson & Johnson Vision Care, Inc.7500 Centurion Pkwy · Jacksonville, FL 32256-0517
✎ GovInfoNow plain-language explainer

What happened, in plain English

Johnson & Johnson Vision Care, Inc. is recalling a specific lot of ACUVUE OASYS for ASTIGMATISM brand contact lenses because some packages may have an incomplete seal. The affected product is a 6-pack with Base Curve 8.6 and Refractive Power -1.00D or -1.25D x 100. Only 300 lenses were distributed to California. Read more at govinfonow.com/recall/68857-johnson-johnson-vision-care-acuvue-oasys-contact-lenses-recall-incomplete.

Source Summary by GovInfoNow · govinfonow.com/recall/68857-johnson-johnson-vision-care-acuvue-oasys-contact-lenses-recall-incomplete · Updated October 13, 2026 · FDA enforcement record: FDA #Z-1131-2019

Cite this page

“ACUVUE OASYS Contact Lens Recall: Incomplete Seal Hazard.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/68857-johnson-johnson-vision-care-acuvue-oasys-contact-lenses-recall-incomplete. Based on FDA recall #Z-1131-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1131-2019%22&limit=1).

Why it’s dangerous

An incomplete packaging seal can compromise the sterility of the contact lens solution inside the package. This increases the risk that the lens could be contaminated, potentially leading to eye infections or irritation when worn.

Who’s affected

Consumers in California who purchased the specific ACUVUE OASYS for ASTIGMATISM contact lenses with lot number B00RWF0 and UPC 733905669460.

How to tell if you have this one

Look for ACUVUE OASYS for ASTIGMATISM brand contact lenses in a 6-pack box. Check the lot number on the box and individual package for B00RWF0 and the UPC code 733905669460. The product has a Base Curve of 8.6 and Refractive Power of -1.00D or -1.25D x 100.

  • Brand
    ACUVUE
  • Product
    ACUVUE OASYS for ASTIGMATISM brand contact lenses, Base Curve 8.6 Refractive Power -1.00D, -1.25D x 100, 6 pack
  • Category
    Medical device

Where it went and when

Where it was distributed

Distributed in California.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distributed to California.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California.

Recall timeline

FDA terminated this recall 2.7 years after the firm started it.

1. Firm started the recall: Mar 11, 201912. FDA classified it Class II: Apr 11, 201923. Published in FDA’s Enforcement Report: Apr 17, 201934. FDA terminated the recall: Dec 6, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1131-2019 (March 11, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1131-2019 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA